RARA and leukemia: The promyelocytic leukemia (PML) gene was first described in the early 1990s at the point of chromosomal translocation t (15, 17), where it was found to encode an oncogenic chimeric protein emerging from the fusion of PML and the retinoic acid receptor alpha (RAR‐α) in patients with acute promyelocytic leukemia (APL).